Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr.
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company…More
NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company…More